Posted by Michael Wonder on 20 May 2019
Trump administration postpones some Medicare drug cost proposals
17 May 2019 - The administration says it will not give health plans the authority to negotiate pricing for certain drugs considered protected classes.
The Trump administration has decided to put part of its Medicare drug cost-cutting proposals on hold, for now, announcing that it will not give health plans the authority to negotiate pricing for certain drugs considered protected classes and will not require pharmacies to make sure Medicare patients get the lowest price on prescriptions.
The Centers for Medicare and Medicaid said Thursday it will not be implementing its lowest pharmacy price proposal for 2020, after receiving more than 4,000 comments on the rule.
